VP Harris, DEA, FDA Eye Cannabis: Key Changes Ahead, Here's What One Expert Predicts
VP Harris, DEA, FDA Eye Cannabis: Key Changes Ahead, Here's What One Expert Predicts
美国食品药品管理局缉毒局副总裁哈里斯：未来的关键变化，这是一位专家的预测
Vice President Harris's urgent call to the DEA to expedite the rescheduling of cannabis marks a crucial turning point in national drug policy, as analyzed in a comprehensive equity research report by Zuanic & Associates.
正如Zuanic & Associates在一份综合股票研究报告中分析的那样，哈里斯副总统紧急呼吁缉毒局加快大麻的重新安排，这标志着国家毒品政策的关键转折点。
The report delves into the implications of Harris's push as well as the Department of Health and Human Services' (HHS) engagement with the Justice Department's Office of Legal Counsel on the complexities of altering cannabis's legal status.
该报告深入探讨了哈里斯的推动以及卫生与公共服务部（HHS）与司法部法律顾问办公室的合作对改变大麻法律地位的复杂性的影响。
In addition, senior analyst Pablo Zuanic addresses critical industry questions, covering FDA oversight, prescription criteria, insurance reimbursement, and the effects of legalization and rescheduling...
此外，高级分析师Pablo Zuanic还解决了...
登录免费看全文
登录/注册